Bryn Mawr Trust CO Novo Nordisk A S Transaction History

Bryn Mawr Trust CO

$4.09 Billion
Q3 2025

A detailed history of Bryn Mawr Trust CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Bryn Mawr Trust CO holds 11,779 shares of NVO stock, worth $570,810. This represents 0.02% of its overall portfolio holdings.

Number of Shares

11,779

Previous 15,084 21.91%

Holding current value

$570,810

Previous $837,000 21.98%

% of portfolio

0.02%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 20, 2025	SELL	$45.38 - $71.7 $149,980 - $236,968	-3,305 Reduced 21.91%	11,779 $653,000
Q3 2025 Oct 28, 2025	SELL	$45.38 - $71.7 $172,943 - $273,248	-3,811 Reduced 20.17%	15,084 $837,000
Q2 2025 Jul 28, 2025	BUY	$58.08 - $81.05 $90,720 - $126,600	1,562 Added 9.01%	18,895 $1.3 Million
Q1 2025 May 08, 2025	SELL	$69.3 - $90.95 $176,576 - $231,740	-2,548 Reduced 12.82%	17,333 $1.2 Million
Q4 2024 Jan 28, 2025	SELL	$85.0 - $120.04 $775,030 - $1.09 Million	-9,118 Reduced 31.44%	19,881 $1.71 Million

Q3 2024 Nov 25, 2024	BUY	$119.07 - $145.42 $1.6 Million - $1.95 Million	13,437 Added 86.34%	28,999 $3.45 Million
Q2 2024 Aug 08, 2024	SELL	$122.71 - $146.91 $58,409 - $69,929	-476 Reduced 2.97%	15,562 $2.22 Million
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $23,689 - $31,533	232 Added 1.47%	16,038 $2.06 Million
Q3 2023 Nov 15, 2023	BUY	$90.94 - $199.54 $705,421 - $1.55 Million	7,757 Added 96.37%	15,806 $1.44 Million
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $143,813 - $159,183	-922 Reduced 10.28%	8,049 $1.3 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $27,262 - $32,782	-206 Reduced 2.24%	8,971 $1.43 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $155,211 - $190,478	1,629 Added 21.58%	9,177 $914,000
Q2 2022 Aug 11, 2022	SELL	$103.24 - $121.81 $1.05 Million - $1.23 Million	-10,133 Reduced 57.31%	7,548 $841,000
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $24,392 - $29,485	-262 Reduced 1.46%	17,681 $1.96 Million
Q4 2021 Feb 10, 2022	SELL	$95.88 - $117.08 $10,738 - $13,112	-112 Reduced 0.62%	17,943 $2.01 Million
Q2 2021 Jul 29, 2021	SELL	$67.66 - $84.76 $27,131 - $33,988	-401 Reduced 2.17%	18,055 $1.51 Million
Q1 2021 Apr 23, 2021	SELL	$67.06 - $75.82 $65,651 - $74,227	-979 Reduced 5.04%	18,456 $1.24 Million
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $8,279 - $9,128	-130 Reduced 0.66%	19,435 $1.35 Million
Q1 2020 May 08, 2020	SELL	$49.46 - $64.78 $22,652 - $29,669	-458 Reduced 2.29%	19,565 $1.18 Million
Q4 2019 Feb 11, 2020	SELL	$49.86 - $58.26 $20,691 - $24,177	-415 Reduced 2.03%	20,023 $1.16 Million
Q3 2019 Oct 24, 2019	BUY	$47.54 - $53.43 $52,864 - $59,414	1,112 Added 5.75%	20,438 $1.06 Million
Q3 2018 Nov 15, 2018	BUY	$46.76 - $51.24 $11,690 - $12,810	250 Added 1.31%	19,326 $911,000
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $9,478 - $10,789	-214 Reduced 1.11%	19,076 $879,000
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $793,783 - $949,453	19,290	19,290 $929,000

Others Institutions Holding NVO

# of Institutions

1,693

Shares Held

303M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Account

Bryn Mawr Trust CO Novo Nordisk A S Transaction History